Variant report
Variant | nsv1015626 |
---|---|
Chromosome Location | chr8:108011245-108057385 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:107858278..107858789-chr8:108024820..108025365,2 | MCF-7 | breast: | |
2 | chr1:38477248..38478946-chr8:108022853..108025135,2 | MCF-7 | breast: | |
3 | chr8:108046046..108048588-chr8:108049288..108050905,2 | K562 | blood: | |
4 | chr8:108046046..108048588-chr8:108049288..108050905,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000183520 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550202924 | chr8:108011316-108011317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2927094 | chr8:108011369-108011370 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs535827366 | chr8:108011389-108011390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529146519 | chr8:108011399-108011400 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139748019 | chr8:108011436-108011437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11985867 | chr8:108011442-108011443 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs144532943 | chr8:108011444-108011445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369679205 | chr8:108011445-108011446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557815135 | chr8:108011465-108011466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181693583 | chr8:108011481-108011482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34223953 | chr8:108011488-108011489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113466796 | chr8:108011506-108011507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556632676 | chr8:108011613-108011614 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536748266 | chr8:108011644-108011645 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186044904 | chr8:108011645-108011646 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566569439 | chr8:108011646-108011647 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535714996 | chr8:108011679-108011680 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542026881 | chr8:108011705-108011706 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73699687 | chr8:108011724-108011725 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs34615941 | chr8:108011725-108011726 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs555290700 | chr8:108011737-108011738 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564586800 | chr8:108011768-108011769 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367561522 | chr8:108011778-108011779 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575048226 | chr8:108011830-108011831 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531647810 | chr8:108011836-108011837 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190511779 | chr8:108011849-108011850 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561974337 | chr8:108011850-108011851 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371551631 | chr8:108011856-108011857 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs3019958 | chr8:108011886-108011887 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs538485860 | chr8:108011912-108011913 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367651819 | chr8:108011913-108011914 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149194751 | chr8:108011959-108011960 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143265286 | chr8:108011961-108011962 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183003090 | chr8:108011967-108011968 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151273556 | chr8:108012001-108012002 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10101809 | chr8:108012065-108012066 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs569730715 | chr8:108012131-108012132 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544010289 | chr8:108012141-108012142 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186326257 | chr8:108012143-108012144 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568428258 | chr8:108012154-108012155 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558696068 | chr8:108012244-108012245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs202101900 | chr8:108012247-108012248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76528272 | chr8:108012268-108012269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140520946 | chr8:108012288-108012289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368468109 | chr8:108012293-108012294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147032452 | chr8:108012306-108012307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138315957 | chr8:108012326-108012327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190937214 | chr8:108012335-108012336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558014117 | chr8:108012337-108012338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142855252 | chr8:108012338-108012339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastric cancer | 22539939 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:108005400-108011600 | Weak transcription | Aorta | Aorta |
2 | chr8:108011000-108013600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr8:108011600-108012200 | ZNF genes & repeats | Aorta | Aorta |
4 | chr8:108011600-108013000 | Enhancers | Adipose Nuclei | Adipose |
5 | chr8:108012400-108013000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr8:108012400-108014200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr8:108012600-108012800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr8:108012600-108013400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr8:108012800-108019200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr8:108013000-108013400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
11 | chr8:108013400-108013800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr8:108024800-108025200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr8:108032800-108033600 | Enhancers | Ovary | ovary |
14 | chr8:108033000-108033400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr8:108036400-108036800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr8:108037400-108038400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr8:108040800-108042000 | ZNF genes & repeats | Aorta | Aorta |